Your Sorted CME/CE Activities

Novel Therapeutic Approaches to Improve Outcomes for Patients with PAH
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Currently, therapies for treating pulmonary hypertension have been used alone and in combination to demonstrate improvements in quality of life and hemodynamic parameters as well as in slowing disease progression; however, beneficial effects on survival are limited. None offer a cure against PAH nor directly address the underlying cellular proliferation that leads to increased pulmonary arterial pressure, and the median survival rate remains at 61% at five years after diagnosis. Extensive research efforts have led to the emergence of innovative therapeutic approaches in PAH. This on-demand webcast focuses on several important aspects of PAH management, including a discussion of the challenges diagnosing and treating patients, clinical trial data on emerging therapeutics for the management of PAH, and a review of strategies to optimize outcomes for patients with PAH.
Review the activity and claim AMA, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.

Aaron Waxman, MD, PhD, FACP, FCCP Aaron Waxman, MD, PhD, FACP, FCCP
Director, Pulmonary Vascular Disease Program
Executive Director, Center for Pulmonary Heart Diseases
Brigham and Women's Hospital, Heart and Vascular Center
Mardi Gomberg-Maitland, MD, MSc Mardi Gomberg-Maitland, MD, MSc
Chief Research Officer
George Washington Office of Clinical Research
Director, Pulmonary Hypertension
George Washington University School of Medicine and Health Sciences

Supported by independent educational grants from
Merck Sharp & Dohme LLC a subsidiary of Merck & Co., Inc.

Launch Date: September 30, 2022
Release Date: September 15, 2022
Expiration Date: August 31, 2023

August 31, 2023
Mini Module